Purine Metabolic Adaptation Protects Endothelium from Flow-Induced DNA Damage and Atherosclerosis

A recent study published in the Proceedings of the National Academy of Sciences highlights a critical mechanism underlying atherosclerosis, a leading cause of death globally. Despite the widespread use of lipid-lowering therapies, vascular injury driven by nonlipid factors remains poorly understood. This research identifies that endothelial cells located in regions of disturbed blood flow accumulate significant DNA damage, which contributes to the development of atherosclerotic plaques. The study reveals that purine metabolic adaptation serves as a protective response, shielding the endothelium from this flow-induced DNA damage. By elucidating the metabolic pathways involved, the findings offer new insights into the nonlipid drivers of vascular injury. This discovery suggests potential therapeutic targets beyond traditional cholesterol management, addressing a gap in current cardiovascular treatments. The research underscores the importance of hemodynamic forces and cellular metabolism in vascular health, providing a deeper understanding of how mechanical stress translates into biological damage and disease progression in arterial walls.